title: Inhibition of carcinoma formation and of vascular invasion in grafts of radiation-initiated thyroid clonogens by unirradiated thyroid cells.
abstract: Quantitative transplantation techniques have been employed to study radiogenic cancer initiation frequency and cell interactions during promotion/progression in grafted clonogenic rat thyroid epithelial cells. The graft recipients were surgically thyroidectomized and maintained on a diet containing less than 50 ng iodine per g. The results confirm that radiogenic initiation is a common cellular event; one of approximately 32 surviving 5-Gy-irradiated thyroid clonogens gave rise to cancer in grafts initially containing approximately 11 clonogens per transplantation site. The data demonstrate that the efficiency of promotion/progression is inversely related to grafted irradiated cell number. As the number of transplanted surviving irradiated clonogens was increased progressively from approximately 11 to approximately 720 clonogens per graft site, the carcinoma frequency per grafted clonogen progressively decreased to one per approximately 920. Addition of unirradiated thyroid cells to the transplant inocula further suppressed promotion/progression of radiation-initiated thyroid clonogens. Furthermore, the probability of vascular invasion, a reflection of metastatic potential in carcinomas which arose from irradiated grafted thyroid clonogens, was reduced by addition of unirradiated thyroid cells to the transplant inocula. Assays of thyroid stimulating hormone (TSH) titers in the sera of thyroidectomized rats 44 weeks after transplantation of clonogenic thyroid cells indicate that the suppression of neoplastic promotion/progression observed with increased numbers of cells per graft site is due at least in part to feed-back inhibition of TSH production by thyroid hormone of graft origin. Whether local cellular interactions are also involved in this inhibitory process is currently under investigation.
authors.affiliation: Department of Human Oncology, University of Wisconsin Clinical Cancer Center, Madison 53792.
authors.forename: H
authors.initials: H
authors.lastname: Watanabe
authors.forename: M A
authors.initials: MA
authors.lastname: Tanner
authors.forename: F E
authors.initials: FE
authors.lastname: Domann
authors.forename: M N
authors.initials: MN
authors.lastname: Gould
authors.forename: K H
authors.initials: KH
authors.lastname: Clifton
mesh_terms: D000818:Animals; D002277:Carcinoma / Q000517:prevention & control*; D002999:Clone Cells; D008297:Male; D009368:Neoplasm Transplantation; D009381:Neoplasms, Radiation-Induced / Q000517:prevention & control*; D009360:Neoplastic Cells, Circulating; D051381:Rats; D011916:Rats, Inbred F344; D013961:Thyroid Gland / Q000528:radiation effects* / Q000637:transplantation; D013964:Thyroid Neoplasms / Q000517:prevention & control*; D013972:Thyrotropin / Q000097:blood
chemical_list: D013972:Thyrotropin